CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale SVP, Chief Legal Officer sold 9,366 shares at $5.39 ($50,516)
- 4 Planned sale Chief Executive Officer sold 44,274 shares at an average $5.31 ($234,884)
- 4 Open-market sale Chief Financial Officer sold 9,035 shares at $5.39 ($48,730)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, Chief Legal Officer sold 688 shares at $5.43 ($3,736)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 4,718 shares at $6.93 ($32,683)
- 4 Open-market sale Chief Financial Officer sold 15,000 shares at $7.36 ($110,358)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Financial Officer sold 1,502 shares at $6.64 ($9,975)
- 144 Insider Sale of Securities
Page 7 of 66 · 1,318 filings